EL
ELEAF.US EL.En. S.p.A
- Market cap
- USD 1.38B
- P/E
- 25.4x
- P/B
- 2.95x
- ROE
- 12.4%
- Dividend yield
- 1.69%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is ELEAF.US undervalued?
Graham numberELEAF.US trades 82.4% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
EL.En. S.p.A fundamental analysis
No fundamental analysis for EL.En. S.p.A yet.
EL.En. S.p.A stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About EL.En. S.p.A
EL.En. S.p.A. engages in the production, research and development, distribution, and sale of laser systems in Italy, Rest of Europe, and internationally. The company offers laser systems for the medical sector and the industrial sector. It also develops, manufactures, and markets products, including solid-state laser, semiconductor laser, active fiber laser, dye lasers, and CO2 laser, as well as radio frequency, microwaves, frequency conversion systems, and high-intensity el…
Full company profileEL.En. S.p.A financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
EL.En. S.p.A annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 255M | 306M | 348M | 401M | 408M | 571M | 674M | 576M | 566M | 591M | 493M |
| Gross Profit | 109M | 123M | 134M | 153M | 136M | 206M | 243M | 230M | 239M | 254M | 242M |
| Operating Income | 27.6M | 26.6M | 27.5M | 34.7M | 24.7M | 59.3M | 75.3M | 73.8M | 71.8M | 72.2M | 85.6M |
| EBITDA | - | 31.4M | 34.1M | 45.8M | 36.1M | 75.4M | 89.5M | 88.1M | 97.3M | 85.5M | 96.2M |
| Net Income | 40.4M | 15.6M | 16.8M | 26.0M | 20.3M | 45.4M | 55.1M | 48.2M | 51.6M | 43.4M | 52.2M |
| EPS | - | 0.20 | 0.22 | 0.33 | 0.26 | 0.57 | 0.69 | 0.60 | 0.64 | 0.54 | 0.65 |
| Balance Sheet | |||||||||||
| Total Assets | 301M | 335M | 360M | 425M | 470M | 651M | 736M | 719M | 741M | 628M | 633M |
| Total Liabilities | 108M | 131M | 141M | 185M | 230M | 363M | 379M | 344M | 330M | 200M | 198M |
| Shareholders' Equity | 193M | 204M | 219M | 241M | 241M | 288M | 357M | 375M | 411M | 412M | 420M |
| Cash & Short-term Investments | 97.6M | 97.4M | 81.0M | 97.0M | 124M | 181M | 163M | 131M | 147M | 174M | 137M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 30.3M | 17.1M | 11.9M | 37.7M | 39.4M | 79.5M | 2.12M | 12.2M | 83.1M | 70.8M | - |
| Capital Expenditure | 10.3M | 3.12M | 25.9M | 20.6M | 11.1M | 14.7M | 17.4M | 13.4M | 9.46M | 11.6M | 0.00 |
| Free Cash Flow | - | 13.3M | -14.6M | 16.1M | 33.6M | 63.4M | -16.3M | -1.14M | 73.6M | 59.2M | - |
| Ratios | |||||||||||
| ROE | 21.0% | 7.7% | 7.7% | 10.8% | 8.4% | 15.8% | 15.5% | 12.8% | 12.6% | 10.5% | 12.4% |
| ROA | 13.4% | 4.7% | 4.7% | 6.1% | 4.3% | 7.0% | 7.5% | 6.7% | 7.0% | 6.9% | 8.2% |
| Net Profit Margin | 15.9% | 5.1% | 4.8% | 6.5% | 5.0% | 8.0% | 8.2% | 8.4% | 9.1% | 7.3% | 10.6% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
EL.En. S.p.A dividends
- Dividend yield
- 1.69%
- Forward dividend
- 0.29 USD
- Payout ratio
- 43.1%
- Ex-dividend date
- May 26, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | EUR 18.7M | 0.23 | 43.1% |
| 2024 | EUR 17.1M | 0.21 | 33.0% |
| 2023 | EUR 18.9M | 0.24 | 39.2% |
| 2022 | EUR 16.0M | 0.20 | 29.0% |
| 2021 | EUR 7.97M | 0.10 | 17.5% |
| 2020 | EUR 7.97M | 0.10 | 39.3% |
| 2019 | USD 7.72M | 0.10 | 29.7% |
| 2018 | USD 8.43M | 0.11 | 50.2% |
| 2017 | USD 7.72M | 0.10 | 49.4% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 4:1 on Aug 2, 2021.
Who owns EL.En. S.p.A
- Insiders 41.90%
- Institutions 30.00%
- Public & others 28.10%
- Shares outstanding 80.2M
- Free float 42.2M
EL.En. S.p.A company profile
- Company name
- EL.En. S.p.A
- Ticker
- ELEAF.US
- ISIN
- IT0005188336
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 1,441
- Fiscal year end
- December
- Address
- Via Baldanzese, 17, Calenzano, FI, Italy, 50041
- Phone
- 39 05 58 82 68 07
- Website
- elengroup.com
About EL.En. S.p.A
EL.En. S.p.A. engages in the production, research and development, distribution, and sale of laser systems in Italy, Rest of Europe, and internationally. The company offers laser systems for the medical sector and the industrial sector. It also develops, manufactures, and markets products, including solid-state laser, semiconductor laser, active fiber laser, dye lasers, and CO2 laser, as well as radio frequency, microwaves, frequency conversion systems, and high-intensity electromagnetic fields. In addition, the company is involved in medical research and development activities, such as body shaping, gynecology and urology, dermatology sector, and hair removal; industrial research and development, including metal cutting, dies, marking, and textile and jeans. EL.En. S.p.A. was founded in 1981 and is headquartered in Calenzano, Italy.
EL.En. S.p.A management
3- Mr. Gabriele ClementiPresident, Chief Executive Officer & Director · born 1951
- Engineer Andrea CangioliMD & Executive Director · born 1965
- Dr. Enrico RomagnoliInvestor Relations Manager, Manager of the Financial Department & Executive Officer